REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTekCapital Regulatory News (TEK)

Share Price Information for TekCapital (TEK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.05
Bid: 7.90
Ask: 8.20
Change: -0.06 (-0.75%)
Spread: 0.30 (3.797%)
Open: 8.00
High: 7.94
Low: 7.94
Prev. Close: 7.94
TEK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Intellectual Property Update

6 Mar 2024 07:00

RNS Number : 7248F
MicroSalt PLC
06 March 2024
 

 

6 March 2024

MicroSalt plc

("MicroSalt" or the "Company")

 

Intellectual Property ("IP") Update

 

MicroSalt plc, (AIM: SALT) a company producing full-flavour, low-sodium salt for food manufacturers and consumers, is pleased to announce that it has received a Notice of Allowance from the United States Patent and Trademark Office for Patent Application No. 18/175,028.

 

The Patent Application entitled Low Sodium Salt Composition, concerns the production of MicroSalt, a low-sodium salt that adheres better to foods than a traditional salt (which is not adhered to a carrier particle).

 

Receipt of a Notice of Allowance indicates that the claims in the patent application are patentable. MicroSalt expect the patent will be granted upon completion of certain administrative matters in short course. Once granted, the patent is expected to expire in 2039.

 

This Notice of Allowance relates to one of the 14 pending patent applications described in the Company's admission document dated 27 January 2024. MicroSalt also has counterpart patent applications with claims directed to similar subject matter as the Patent Application 18/175,028 pending in countries including China, Chile, Australia, Brazil, Europe, Canada, Japan, Russia, Mexico, India and Hong Kong.

 

MicroSalt also owns a previously issued United States patent directed to its salt carrier product and production processes, and a United States provisional patent application directed to additional innovations.

 

Rick Guiney, CEO of Microsalt, said:

 

"This Notice of Allowance further strengthens our IP position in the global low sodium market whilst providing additional evidence of our thought leadership position in the battle to lower sodium consumption worldwide."

 

 For more information, please visit www.microsaltinc.co, follow on X @microSaltPLC or contact:

 

MicroSalt plc

Via Flagstaff

Rick Guiney, CEO 

 

 

Zeus (Nominated Adviser and Broker)

David Foreman / James Edis (Investment Banking)

Dom King (Corporate Broking), Rupert Woolfenden (Sales)

 

+44 (0)20 3829 5000

Flagstaff PR (Financial IR/FPR)  

+44 (0)20 7129 1474

Tim Thompson / Alison Allfrey / Anna Probert

microsalt@flagstaffcomms.com

 

 

Notes to Editors

 

MicroSalt® produces a patented full-flavour, low-sodium salt for food manufacturers and consumers.

 

MicroSalt is a major potential disruptor in the food market, thanks to its micron sized particles which deliver the same sense of saltiness to a wide range of foods but with approximately 50% less sodium. Excess sodium consumption is a significant contributor to cardiovascular disease and MicroSalt's solution meets the rising demand for healthier alternatives to traditional salt. The WHO has set a target for reducing global sodium intake by 30% by 2025, which it estimates will save 7 million lives by 2030.

 

Each year, cardiovascular disease costs the UK £19 billion - if the average salt intake was reduced by one gram per day, it has been estimated that 4,147 lives and £288 million would be saved each year in the UK. As a nation, the UK consumes 183 million kilograms of salt each year, and 70% of the typical person's sodium intake is hidden in processed foods.

 

Operational since 2018, MicroSalt uses a patent-protected technology which helps create high barriers to entry within the reduced-sodium salt market.

 

The Directors believe that MicroSalt is well positioned to capture growth in the low sodium market, which is expected to grow exponentially, and that there is also scope to enter the larger salt market.

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDUVUORSRUORUR
Date   Source Headline
8th Mar 20217:00 amRNSBelluscura FDA Clearance
5th Feb 20217:00 amRNSSalarius Update
4th Feb 20212:05 pmRNSSecond Price Monitoring Extn
4th Feb 20212:00 pmRNSPrice Monitoring Extension
2nd Feb 20212:47 pmRNSNotification of Major Shareholding
1st Feb 202111:05 amRNSSecond Price Monitoring Extn
1st Feb 202111:00 amRNSPrice Monitoring Extension
1st Feb 20219:05 amRNSSecond Price Monitoring Extn
1st Feb 20219:00 amRNSPrice Monitoring Extension
1st Feb 20217:00 amRNSCommencement of Trading OTCQB Venture Mkt in USA
12th Jan 20212:05 pmRNSSecond Price Monitoring Extn
12th Jan 20212:00 pmRNSPrice Monitoring Extension
6th Jan 20217:00 amRNSLucyd -Crowdfunding and launch Lyte E glasses
21st Dec 202012:35 pmRNSHolding(s) in Company
7th Dec 20202:49 pmRNSNotification of Major Holdings
3rd Dec 20203:46 pmRNSNotification of Major Holdings
3rd Dec 20209:05 amRNSSecond Price Monitoring Extn
3rd Dec 20209:00 amRNSPrice Monitoring Extension
3rd Dec 20207:00 amRNSBelluscura Update
2nd Dec 20209:00 amRNSPrice Monitoring Extension
2nd Dec 20207:00 amRNSSalarius launches on Amazon North America
1st Dec 20203:19 pmRNSTotal Voting Rights
18th Nov 20202:05 pmRNSSecond Price Monitoring Extn
18th Nov 20202:00 pmRNSPrice Monitoring Extension
17th Nov 20204:56 pmRNSNotification of Major Holdings
17th Nov 20207:00 amRNSPlacing to Raise £380,000
30th Oct 20206:08 pmRNSTotal Voting Rights
28th Oct 20207:00 amRNSLucyd Patents
5th Oct 20207:00 amRNSPortfolio Company Update: Guident Ltd
1st Oct 202010:18 amRNSExercise of Stock Options and Total Voting Rights
28th Sep 20207:00 amRNSLucyd Ecommerce management appointment
24th Sep 20207:00 amRNSSalarius Mexican Distribution Agreement
21st Sep 20207:00 amRNSGuident Files Additional Patent
16th Sep 20207:00 amRNSSalarius distribution agreement
14th Sep 20207:00 amRNSGuident Update
7th Sep 20207:00 amRNSGuident Update
27th Aug 20201:44 pmRNSGrant of Stock Options
21st Aug 20207:00 amRNSUnaudited Half-Yearly Report
27th Jul 202012:49 pmRNSResults of Annual General Mtg & Directorate Change
27th Jul 20207:00 amRNSNotice of Investor and Analyst Conference Call
22nd Jul 20207:00 amRNSLucyd Update
13th Jul 20207:00 amRNSInvestor and Analyst Conference Call
7th Jul 20201:16 pmRNSNotification of Major Holdings
30th Jun 20204:43 pmRNSNotice of AGM
17th Jun 20202:52 pmRNSNotification of Major Holdings
17th Jun 20207:30 amRNSPortfolio Company Update: Belluscura plc
16th Jun 20207:00 amRNSGuident Update
29th May 20203:18 pmRNSPosting of Annual Report & Total Voting Rights
22nd May 20201:25 pmRNSNotification of Major Shareholdings
22nd May 20207:00 amRNSGuident Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.